ambroxol

Ukraine

Drugs containing this active substance

  • PULMOBRIZ®

    The drug is used to treat acute and chronic respiratory diseases accompanied by impaired secretion and excretion of phlegm. This includes bronchitis, pneumonia, bronchial asthma, laryngitis, tracheitis, and other diseases.

    Form: powder for oral suspension

    Active substance Dosage
    acetylcysteine 200 mg
    ambroxol 30 mg

    ATC: R05CB10

    Manufacturer: Sava HealthCare Ltd

  • The drug is used to treat acute and chronic respiratory diseases (e.g., bronchitis, pneumonia) accompanied by impaired mucus clearance. It also helps with rhinitis, sinusitis, and otitis by reducing swelling and thinning secretions.

    Form: powder for oral suspension

    Active substance Dosage
    ambroxol 30 mg/5 ml
    loratadine 5 mg/5 ml

    ATC: R05C

    Manufacturer: Sava HealthCare Ltd

  • The drug is used to treat acute and chronic respiratory diseases (e.g., bronchitis, pneumonia) accompanied by impaired sputum clearance. It also helps with allergic rhinitis, sinusitis, and otitis to reduce swelling and thin the secretion.

    Form: tablets

    Active substance Dosage
    ambroxol 60 mg
    loratadine 5 mg

    ATC: R05C

    Manufacturer: Sava HealthCare Ltd

  • The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired secretion and excretion of phlegm (e.g., bronchitis, pneumonia, bronchial asthma, laryngitis, tracheitis, and others).

    Form: tablets, film-coated

    Active substance Dosage
    acetylcysteine 200 mg
    ambroxol 30 mg

    ATC: R05CB10

    Manufacturer: Evertoxgen Life Sciences Limited

  • The drug is used for the symptomatic treatment of respiratory diseases that have an allergic component and are accompanied by impaired mucus secretion and difficulty in its excretion.

    Form: tablets

    Active substance Dosage
    ambroxol 60 mg
    loratadine 5 mg

    ATC: R05C

    Manufacturer: Evertoxgen Life Sciences Limited

  • The drug is used for the treatment of acute and chronic bronchial diseases accompanied by difficulties in mucus excretion. It also helps relieve severe throat pain in uncomplicated respiratory diseases in adults.

    Form: solution, oral

    Active substance Dosage
    ambroxol 50 mg/ml

    ATC: R05CB06

    Manufacturer: ITC Production S.R.L.

  • The drug is used for the treatment of bronchial asthma, chronic obstructive bronchitis, and pulmonary emphysema.

    Form: tablets

    Active substance Dosage
    ambroxol 15 mg
    salbutamol 4 mg

    ATC: R03AK04

    Manufacturer: PJSC "Scientific and Production Center "Boryspilskyy Chemical-Pharmaceutical Plant" (full-cycle manufacturing)